As regular readers will know, Molson Coors (TAP) had its issues even before COVID hit. In very broad terms I think you can boil those down to two points. Firstly, the company took on a bunch of debt to buy out the rest of the MillerCoors JV in 2016. Debt…
Stocks
-
-
StocksFinancial
Toronto Dominion: Set For A Good 2021, But A Return To Pre-COVID Performance Now Reflected In The Share Price
A year ago it might have been tough to imagine Toronto Dominion (TD) putting down the kind of financial results it has of late. The economic environment was obviously pretty darn scary back then, with the early economic data resembling nothing ever seen before. The potentially devastating impact to bank…
-
Although it comes under a single ticker, Johnson & Johnson (JNJ) is more akin to a giant one-stop healthcare shop. Folks likely know the consumer division thanks to brands like Listerine, Neutrogena and Tylenol. Its pharmaceutical segment sells patented drugs across a range of areas – oncology, immunology, neurology, infectious…
-
StocksConsumer Cyclical
Chipotle Mexican Grill: Good Growth Prospects, But Priced For Perfection At 50x 2022 EPS Estimates
A year ago it would have been difficult to imagine a restaurant stock having a solid 2020. Yet judging by results released early last month, Chipotle (CMG) appears to have managed just that. The Mexican-themed chain posted annual sales of around $6b last year, a 7% rise on 2019 levels.…
-
StocksMedia
ViacomCBS: Up Around 300% Since Last Appearance; 1.15% Dividend Yield Means No Value Case Anymore
It is crazy how cheap media firm ViacomCBS (VIAC) got in the early part of last year. I mean, the CBS and Paramount Pictures owner last featured here back in May 2020. It traded for circa $19 a share at the time. Prior to that, it was covered in late…